NCT03543371

Brief Summary

This study is a sub-study to the large pragmatic Target Temperature Management 2 Trial (TTM2-trial, ClinicalTrials.gov Identifier: NCT02908308), assessing effectiveness of controlled hypothermia after out-of-hospital cardiac arrest (OHCA). This study is designed to provide detailed information on cognition after OHCA and its relationship to associated factors as emotional function, fatigue, and sleep. A secondary aim is to utilize this information to validate a neurocognitive screening battery used 6 months after OHCA in the TTM2-trial. Approximately 7 and 24 months after OHCA, survivors at selected TTM2 study sites will perform a standardized neuropsychological assessment including performance-based tests of cognition and questionnaires of behavioral and emotional function, fatigue, and insomnia. At 1:1 ratio, a control group of myocardial infarction (MI) patients but no occurrence of cardiac arrest will be recruited and perform the same test battery. Group differences at 7 and 24 months will be analyzed per cognitive domain (verbal, visual/constructive, short-term working memory, episodic memory, processing speed, executive functions). Results of the OHCA survivors on the TTM2 neurocognitive screening battery will be compared with neuropsychological test results at 7 months time.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2018

Longer than P75 for all trials

Geographic Reach
3 countries

8 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 17, 2018

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 1, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

July 13, 2018

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 11, 2021

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 23, 2022

Completed
Last Updated

December 19, 2025

Status Verified

September 1, 2023

Enrollment Period

2.5 years

First QC Date

May 17, 2018

Last Update Submit

December 12, 2025

Conditions

Keywords

Neuropsychology

Outcome Measures

Primary Outcomes (1)

  • Cognitive impairment

    Cognitive function in OHCA and MI patients, using composite z-scores from the neuropsychological tests grouped by cognitive domain.

    7 months after the cardiac event

Secondary Outcomes (1)

  • Sensitivity and specificity of the neurocognitive screening battery in the main TTM2-trial

    7 months post-arrest

Other Outcomes (1)

  • Change in cognitive function

    7 months, 24 months after the cardiac event

Study Arms (2)

Cardiac Arrest survivors

Cardiac arrest survivors at selected TTM2-sites only.

Diagnostic Test: Neuropsychological assessment

Myocardial Infarction patients

A control group from a cohort of patients with myocardial infarction with performed coronary angiography but no occurrence of cardiac arrest will be recruited at 1:1 ratio.

Diagnostic Test: Neuropsychological assessment

Interventions

Standardized neuropsychological battery consisting of the following tests and questionnaires: Wechsler Adult Intelligence Scale - Fourth Edition (WAIS-IV) Vocabulary, Delis-Kaplan Executive Function System (D-KEFS) Verbal Fluency, WAIS-IV Block Design, WAIS-IV Matrix Reasoning, WAIS-IV Digit Span, Wechsler Memory Scale - Third Edition (WMS-III) Spatial Span, Rey Auditory Verbal Learning Test (RAVLT), WMS-III Logical Memory, Brief Visuospatial Memory Test-Revised (BVMT-R), Trail Making Test (TMT) A \& B, D-KEFS Color Word Interference Test, Behavioral Assessment of the Dysexecutive Syndrome Dysexecutive Questionnaire (BADS DEX), Multidimensional Fatigue Inventory (MFI-20), Minimal Insomnia Symptom Scale (MISS), Hospital Anxiety and Depression Scale (HADS).

Cardiac Arrest survivorsMyocardial Infarction patients

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

OHCA survivors at TTM2-sites participating in this study. Survivors are invited to partake in this study at the regular six-month follow-up of the TTM2-trial. The cohort of MI patients acting as controls are recruited and assessed at one participating site per country through quality registers.

You may qualify if:

  • OHCA of a presumed cardiac or unknown cause (OHCA cohort only)
  • Sustained return of spontaneous circulation (ROSC) during intensive care - defined as 20 minutes with signs of circulation without the need for chest compressions (OHCA cohort only)
  • Unconsciousness - defined as not being able to obey verbal commands (FOUR-score motor response of \<4) and no verbal response to pain after sustained ROSC (OHCA cohort only)
  • During intensive care - eligible for intensive care without restrictions or limitations (OHCA cohort only)
  • MI with performed coronary angiography (MI cohort only)

You may not qualify if:

  • Temperature on admission \<30°C (OHCA cohort only)
  • On extracorporeal membrane oxygenation (ECMO) prior to return of spontaneous circulation (OHCA cohort only)
  • Obvious or suspected pregnancy
  • Intracranial bleeding (OHCA cohort only)
  • Severe chronic obstructive pulmonary disorder (COPD) with long-term home oxygen therapy
  • Clinical dementia diagnosis before the event
  • Inability to speak the local language well enough to complete the assessment without assistance from an interpreter
  • Inability to meet for a face-to-face examination
  • Clinical Frailty Scale Index ≥8, indicating very severe frailty
  • Cardiac arrest before or in connection with MI (MI cohort only)
  • Active substance abuse

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

Aarhus University Hospital

Aarhus, Denmark

Location

Sahlgrenska University Hospital

Gothenburg, Sweden

Location

Halmstad County Hospital

Halmstad, Sweden

Location

Helsingborg Hospital

Helsingborg, Sweden

Location

Skane University Hospital

Lund, Sweden

Location

Skane University Hospital

Malmo, Sweden

Location

The Essex Cardiothoracic Centre, Basildon and Thurrock University Hospitals NHS Foundation Trust

Basildon, Essex, United Kingdom

Location

University Hospital of Wales, Cardiff and Vale University Health Board

Cardiff, Wales, United Kingdom

Location

Related Publications (4)

  • Blennow Nordstrom E, Lilja G, Vestberg S, Ullen S, Friberg H, Nielsen N, Heimburg K, Evald L, Mion M, Segerstrom M, Grejs AM, Keeble T, Kirkegaard H, Ljung H, Rose S, Wise MP, Rylander C, Unden J, Cronberg T. Neuropsychological outcome after cardiac arrest: a prospective case control sub-study of the Targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest trial (TTM2). BMC Cardiovasc Disord. 2020 Oct 7;20(1):439. doi: 10.1186/s12872-020-01721-9.

    PMID: 33028221BACKGROUND
  • Blennow Nordstrom E, Evald L, Mion M, Segerstrom M, Vestberg S, Ullen S, Heimburg K, Gregersen Oestergaard L, Grejs AM, Keeble TR, Kirkegaard H, Rylander C, Wise MP, Lilja G. Combined use of the Montreal Cognitive Assessment and Symbol Digit Modalities Test improves neurocognitive screening accuracy after cardiac arrest: A validation sub-study of the TTM2 trial. Resuscitation. 2024 Sep;202:110361. doi: 10.1016/j.resuscitation.2024.110361. Epub 2024 Aug 13.

  • Vig A, Vestberg S, Evald L, Mion M, Segerstrom M, Ullen S, Arestedt K, Nielsen N, Cronberg T, Lilja G, Blennow Nordstrom E. Psychometric properties of the Dysexecutive Questionnaire (DEX) in individuals with a previous cardiac event. Neuropsychol Rehabil. 2025 Nov 27:1-21. doi: 10.1080/09602011.2025.2591784. Online ahead of print.

  • Blennow Nordstrom E, Vestberg S, Evald L, Mion M, Segerstrom M, Ullen S, Bro-Jeppesen J, Friberg H, Heimburg K, Grejs AM, Keeble TR, Kirkegaard H, Ljung H, Rose S, Wise MP, Rylander C, Unden J, Nielsen N, Cronberg T, Lilja G. Neuropsychological outcome after cardiac arrest: results from a sub-study of the targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest (TTM2) trial. Crit Care. 2023 Aug 26;27(1):328. doi: 10.1186/s13054-023-04617-0.

MeSH Terms

Conditions

Out-of-Hospital Cardiac ArrestHypoxia-Ischemia, BrainCognition DisordersFatigueSleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Heart ArrestHeart DiseasesCardiovascular DiseasesBrain IschemiaCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesHypoxia, BrainVascular DiseasesHypoxiaSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental DisordersSleep Disorders, IntrinsicDyssomniasSleep Wake Disorders

Study Officials

  • Niklas Nielsen, MD, PhD

    Lund University

    STUDY DIRECTOR
  • Gisela Lilja, PhD, OT

    Lund University

    STUDY DIRECTOR
  • Tobias Cronberg, MD, PhD

    Lund University

    STUDY DIRECTOR
  • Susanna Vestberg, PhD, Lic.Psych.

    Lund University

    STUDY DIRECTOR
  • Erik Blennow Nordström, PhD, Lic.Psych.

    Lund University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 17, 2018

First Posted

June 1, 2018

Study Start

July 13, 2018

Primary Completion

January 11, 2021

Study Completion

May 23, 2022

Last Updated

December 19, 2025

Record last verified: 2023-09

Locations